Drug recalls — page 2
432 recent drug recalls in our current data.
Showing 201–400, newest first.
FDA Class II · Drug · July 29, 2026
Lack of Assurance of Sterility
Company / brand: Rohto-Mentholatum (Vietnam) Co recalls
Affected product: Rohto Cooling Eye Drops Cool Relief (naphazoline hydrochloride 0 recall status
Official ID D-0722-2026 ·
Official record ↗
FDA Class II · Drug · July 29, 2026
Lack of Assurance of Sterility
Company / brand: Rohto-Mentholatum (Vietnam) Co recalls
Affected product: Rohto Cooling Eye Drops Dry Aid (povidone 0 recall status
Official ID D-0721-2026 ·
Official record ↗
FDA Class II · Drug · July 29, 2026
Lack of Assurance of Sterility
Company / brand: Rohto-Mentholatum (Vietnam) Co recalls
Affected product: Rohto Cooling Eye Drops Dry Aid (povidone 0 recall status
Official ID D-0720-2026 ·
Official record ↗
FDA Class II · Drug · July 29, 2026
Lack of Assurance of Sterility
Company / brand: Rohto-Mentholatum (Vietnam) Co recalls
Affected product: Rohto Cooling Eye Drops Digi Eye (hypromellose 0 recall status
Official ID D-0719-2026 ·
Official record ↗
FDA Class II · Drug · July 29, 2026
Lack of Assurance of Sterility
Company / brand: Rohto-Mentholatum (Vietnam) Co recalls
Affected product: Rohto Cooling Eye Drops Optic Glow (naphazoline hydrochloride 0 recall status
Official ID D-0718-2026 ·
Official record ↗
FDA Class II · Drug · July 29, 2026
Lack of Assurance of Sterility
Company / brand: Rohto-Mentholatum (Vietnam) Co recalls
Affected product: Rohto Cooling Eye Drops Max Strength (naphazoline hydrochloride 0 recall status
Official ID D-0717-2026 ·
Official record ↗
FDA Class II · Drug · July 29, 2026
Lack of Assurance of Sterility
Company / brand: Rohto-Mentholatum (Vietnam) Co recalls
Affected product: Rohto Cooling Eye Drops Max Strength (naphazoline hydrochloride 0 recall status
Official ID D-0716-2026 ·
Official record ↗
FDA Class II · Drug · July 29, 2026
Lack of Assurance of Sterility
Company / brand: Rohto-Mentholatum (Vietnam) Co recalls
Affected product: Rohto Cooling Eye Drops ALL-IN-ONE (hypromellose 0 recall status
Official ID D-0715-2026 ·
Official record ↗
FDA Class III · Drug · July 29, 2026
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
Company / brand: Asclemed USA recalls
Affected product: Lidolog Kit recall status
Official ID D-0713-2026 ·
Official record ↗
FDA Class II · Drug · July 29, 2026
Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications
Company / brand: Ascend Laboratories recalls
Affected product: Amlodipine and Olmesartan Medoxomil Tablets recall status
Official ID D-0712-2026 ·
Official record ↗
FDA Class II · Drug · July 29, 2026
Subpotent Drug
Company / brand: Major Pharmaceuticals recalls
Affected product: Levothyroxine Sodium Tablets recall status
Official ID D-0711-2026 ·
Official record ↗
FDA Class II · Drug · July 29, 2026
Subpotent Drug
Company / brand: Major Pharmaceuticals recalls
Affected product: Levothyroxine Sodium Tablets recall status
Official ID D-0710-2026 ·
Official record ↗
FDA Class II · Drug · July 29, 2026
Subpotent Drug
Company / brand: Major Pharmaceuticals recalls
Affected product: Levothyroxine Sodium Tablets recall status
Official ID D-0709-2026 ·
Official record ↗
FDA Class II · Drug · July 29, 2026
Subpotent Drug
Company / brand: Major Pharmaceuticals recalls
Affected product: Levothyroxine Sodium Tablets recall status
Official ID D-0708-2026 ·
Official record ↗
FDA Class II · Drug · July 29, 2026
Subpotent Drug
Company / brand: Major Pharmaceuticals recalls
Affected product: Levothyroxine Sodium Tablets recall status
Official ID D-0707-2026 ·
Official record ↗
FDA Class II · Drug · July 29, 2026
Subpotent Drug
Company / brand: Major Pharmaceuticals recalls
Affected product: Levothyroxine Sodium Tablets recall status
Official ID D-0706-2026 ·
Official record ↗
FDA Class II · Drug · July 29, 2026
Subpotent Drug
Company / brand: Major Pharmaceuticals recalls
Affected product: Levothyroxine Sodium Tablets recall status
Official ID D-0705-2026 ·
Official record ↗
FDA Class II · Drug · July 29, 2026
Subpotent Drug
Company / brand: Major Pharmaceuticals recalls
Affected product: Levothyroxine Sodium Tablets recall status
Official ID D-0704-2026 ·
Official record ↗
FDA Class II · Drug · July 29, 2026
Subpotent Drug
Company / brand: Major Pharmaceuticals recalls
Affected product: Levothyroxine Sodium Tablets recall status
Official ID D-0703-2026 ·
Official record ↗
FDA Class II · Drug · July 29, 2026
Subpotent Drug
Company / brand: Major Pharmaceuticals recalls
Affected product: Levothyroxine Sodium Tablets recall status
Official ID D-0702-2026 ·
Official record ↗
FDA Class II · Drug · July 29, 2026
Subpotent Drug
Company / brand: Major Pharmaceuticals recalls
Affected product: Levothyroxine Sodium Tablets recall status
Official ID D-0701-2026 ·
Official record ↗
FDA Class II · Drug · July 29, 2026
Subpotent Drug
Company / brand: Major Pharmaceuticals recalls
Affected product: Levothyroxine Sodium Tablets recall status
Official ID D-0700-2026 ·
Official record ↗
FDA Class II · Drug · July 22, 2026
Lack of Assurance of Sterility: Affected product may exhibit an open or incomplete seal on the packaging of the applicator
Company / brand: CareFusion 213 recalls
Affected product: BD ChloraPrep Clear recall status
Official ID D-0690-2026 ·
Official record ↗
FDA Class II · Drug · July 22, 2026
Lack of Assurance of Sterility
Company / brand: Chiesi USA recalls
Affected product: CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0 recall status
Official ID D-0689-2026 ·
Official record ↗
FDA Class II · Drug · July 22, 2026
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
Company / brand: Bell Pharmaceuticals recalls
Affected product: CAREone recall status
Official ID D-0688-2026 ·
Official record ↗
FDA Class II · Drug · July 22, 2026
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
Company / brand: Bell Pharmaceuticals recalls
Affected product: meijer recall status
Official ID D-0687-2026 ·
Official record ↗
FDA Class II · Drug · July 22, 2026
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
Company / brand: Bell Pharmaceuticals recalls
Affected product: Foster & Thrive recall status
Official ID D-0686-2026 ·
Official record ↗
FDA Class II · Drug · July 22, 2026
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
Company / brand: Bell Pharmaceuticals recalls
Affected product: LEADER recall status
Official ID D-0685-2026 ·
Official record ↗
FDA Class II · Drug · July 22, 2026
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
Company / brand: Bell Pharmaceuticals recalls
Affected product: GOOD NEIGHBOR PHARMACY recall status
Official ID D-0684-2026 ·
Official record ↗
FDA Class II · Drug · July 22, 2026
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
Company / brand: Bell Pharmaceuticals recalls
Affected product: FAMILY Wellness recall status
Official ID D-0683-2026 ·
Official record ↗
FDA Class II · Drug · July 22, 2026
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
Company / brand: Bell Pharmaceuticals recalls
Affected product: AUDIOLOGIST'S CHOICE recall status
Official ID D-0682-2026 ·
Official record ↗
FDA Class II · Drug · July 22, 2026
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
Company / brand: Bell Pharmaceuticals recalls
Affected product: TopCare Health recall status
Official ID D-0681-2026 ·
Official record ↗
FDA Class II · Drug · July 22, 2026
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
Company / brand: Bell Pharmaceuticals recalls
Affected product: QC Quality Choice recall status
Official ID D-0680-2026 ·
Official record ↗
FDA Class II · Drug · July 22, 2026
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
Company / brand: Bell Pharmaceuticals recalls
Affected product: Clinere recall status
Official ID D-0679-2026 ·
Official record ↗
FDA Class II · Drug · July 22, 2026
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
Company / brand: Bell Pharmaceuticals recalls
Affected product: CVS Health recall status
Official ID D-0678-2026 ·
Official record ↗
FDA Class II · Drug · July 22, 2026
Subpotent Drug: Low out of specification assay results performed during long-term stability testing.
Company / brand: Padagis US recalls
Affected product: Nystatin Cream USP recall status
Official ID D-0677-2026 ·
Official record ↗
FDA Class II · Drug · July 15, 2026
cGMP deviations
Company / brand: Shimoga Chemicals recalls
Affected product: Clomiphene Citrate USP Active Pharmaceutical Ingredient (CAS recall status
Official ID D-0691-2026 ·
Official record ↗
FDA Class II · Drug · July 15, 2026
Lack of Sterility Assurance
Company / brand: Reliance Life Sciences Private recalls
Affected product: Azacitidine for Injection 100mg/Vial recall status
Official ID D-0674-2026 ·
Official record ↗
FDA Class II · Drug · July 15, 2026
Lack of Sterility Assurance
Company / brand: Reliance Life Sciences Private recalls
Affected product: Bortezomib for Injection 3 recall status
Official ID D-0673-2026 ·
Official record ↗
FDA Class II · Drug · July 15, 2026
Lack of Sterility Assurance
Company / brand: Reliance Life Sciences Private recalls
Affected product: Pemetrexed for Injection 500mg/Vial recall status
Official ID D-0672-2026 ·
Official record ↗
FDA Class II · Drug · July 15, 2026
Lack of Sterility Assurance
Company / brand: Reliance Life Sciences Private recalls
Affected product: Pemetrexed for Injection 100mg/Vial recall status
Official ID D-0671-2026 ·
Official record ↗
FDA Class II · Drug · July 15, 2026
Subpotent drug
Company / brand: Gasco Industrial recalls
Affected product: Drogueria San Juan Puerto Rico Isopropyl Alcohol 70% recall status
Official ID D-0670-2026 ·
Official record ↗
FDA Class II · Drug · July 15, 2026
Subpotent drug
Company / brand: Gasco Industrial recalls
Affected product: Drogueria San Juan Puerto Rico Isopropyl Alcohol 70% recall status
Official ID D-0669-2026 ·
Official record ↗
FDA Class II · Drug · July 15, 2026
Subpotent drug
Company / brand: Gasco Industrial recalls
Affected product: Drogueria San Juan Puerto Rico Isopropyl Alcohol 70% recall status
Official ID D-0668-2026 ·
Official record ↗
FDA Class II · Drug · July 15, 2026
Subpotent drug
Company / brand: Gasco Industrial recalls
Affected product: Gasco Isopropyl Alcohol 70% recall status
Official ID D-0667-2026 ·
Official record ↗
FDA Class II · Drug · July 15, 2026
Subpotent drug
Company / brand: Gasco Industrial recalls
Affected product: Gasco Isopropyl Alcohol 70% recall status
Official ID D-0666-2026 ·
Official record ↗
FDA Class II · Drug · July 15, 2026
Subpotent drug
Company / brand: Gasco Industrial recalls
Affected product: Gasco Isopropyl Alcohol 70% recall status
Official ID D-0665-2026 ·
Official record ↗
FDA Class II · Drug · July 15, 2026
Failed Impurities/Degradation Specifications
Company / brand: QuVa Pharma recalls
Affected product: Methohexital Sodium recall status
Official ID D-0664-2026 ·
Official record ↗
FDA Class II · Drug · July 15, 2026
Failed Impurities/Degradation Specifications; Formaldehyde levels exceeded specification.
Company / brand: BioMed Laboratories recalls
Affected product: Medline Remedy Specialized Silicone Cream (Hydraguard-D ) recall status
Official ID D-0663-2026 ·
Official record ↗
FDA Class II · Drug · July 15, 2026
Failed Impurities/Degradation Specifications
Company / brand: ONESOURCE SPECIALTY PHARMA recalls
Affected product: Methohexital Sodium for Injection recall status
Official ID D-0662-2026 ·
Official record ↗
FDA Not Yet Classified · Drug · July 8, 2026
CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.
Company / brand: Lupin Pharmaceuticals recalls
Affected product: Glucagon Emergency Kit for Low Blood Sugar recall status
Official ID EVT-99296-c9qbin ·
Official record ↗
FDA Class II · Drug · July 8, 2026
CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.
Company / brand: Lupin Pharmaceuticals recalls
Affected product: Glucagon Emergency Kit for Low Blood Sugar recall status
Official ID D-0723-2026 ·
Official record ↗
FDA Class II · Drug · July 8, 2026
Temperature Abuse: Product was stored incorrectly in a controlled room temperature environment instead of a refrigerated environment.
Company / brand: McKesson recalls
Affected product: Gemcitabine Injection recall status
Official ID D-0714-2026 ·
Official record ↗
FDA Class II · Drug · July 8, 2026
CGMP Deviations; product manufactured in the same facility under the same conditions as the product found to be contaminated
Company / brand: Blaine Labs recalls
Affected product: Revitaderm Wound Care recall status
Official ID D-0699-2026 ·
Official record ↗
FDA Class II · Drug · July 8, 2026
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
Company / brand: Blaine Labs recalls
Affected product: Fungal Fusion ERADICATION Solution recall status
Official ID D-0698-2026 ·
Official record ↗
FDA Class II · Drug · July 8, 2026
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
Company / brand: Blaine Labs recalls
Affected product: TERPENICOL Antifungal Solution recall status
Official ID D-0697-2026 ·
Official record ↗
FDA Class II · Drug · July 8, 2026
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
Company / brand: Blaine Labs recalls
Affected product: vite20 Antifungal Cream recall status
Official ID D-0696-2026 ·
Official record ↗
FDA Class II · Drug · July 8, 2026
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
Company / brand: Blaine Labs recalls
Affected product: TERPENICOL Antifungal Cream (Undecylenic Acid 13%) recall status
Official ID D-0695-2026 ·
Official record ↗
FDA Class II · Drug · July 8, 2026
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
Company / brand: Blaine Labs recalls
Affected product: TRIPENICOL S Antifungal Solution (Undecylenic Acid 25%) recall status
Official ID D-0694-2026 ·
Official record ↗
FDA Class II · Drug · July 8, 2026
CGMP Deviations: product manufactured in the same facility under the same conditions as the product found to be contaminated
Company / brand: Blaine Labs recalls
Affected product: TRIFLUENT PHARMA TRIDERGEL Wound Care Gel recall status
Official ID D-0693-2026 ·
Official record ↗
FDA Class I · Drug · July 8, 2026
Microbial contamination of Non-Sterile Product: samples identified the presence of Lysinibacillus fusiformis and other Bacillus spp
Company / brand: Blaine Labs recalls
Affected product: Revitaderm Wound Care Gel recall status
Official ID D-0692-2026 ·
Official record ↗
FDA Class II · Drug · July 8, 2026
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
Company / brand: Cipla USA recalls
Affected product: Cinacalcet Hydrochloride Tablets recall status
Official ID D-0676-2026 ·
Official record ↗
FDA Class II · Drug · July 8, 2026
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
Company / brand: Cipla USA recalls
Affected product: Cinacalcet Hydrochloride Tablets recall status
Official ID D-0675-2026 ·
Official record ↗
FDA Class II · Drug · July 8, 2026
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
Company / brand: Cipla USA recalls
Affected product: Cinacalcet Hydrochloride Tablets recall status
Official ID D-0661-2026 ·
Official record ↗
FDA Class II · Drug · July 8, 2026
Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.
Company / brand: Lannett Company recalls
Affected product: Dextroamphetamine Saccharate recall status
Official ID D-0660-2026 ·
Official record ↗
FDA Class II · Drug · July 8, 2026
Lack of Assurance of Sterility
Company / brand: Asclemed USA recalls
Affected product: Lidocaine HCl Injection USP recall status
Official ID D-0659-2026 ·
Official record ↗
FDA Class II · Drug · July 8, 2026
Lack of Assurance of Sterility
Company / brand: Asclemed USA recalls
Affected product: Accucaine recall status
Official ID D-0658-2026 ·
Official record ↗
FDA Class II · Drug · July 8, 2026
CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a different product.
Company / brand: Boehringer Ingelheim Pharmaceuticals recalls
Affected product: Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets) recall status
Official ID D-0657-2026 ·
Official record ↗
FDA Class II · Drug · July 8, 2026
Subpotent Drug
Company / brand: ACCORD HEALTHCARE recalls
Affected product: Levothyroxine Sodium Tablets recall status
Official ID D-0656-2026 ·
Official record ↗
FDA Class II · Drug · July 8, 2026
Presence of Foreign Substance
Company / brand: Lupin Pharmaceuticals recalls
Affected product: prednisoLONE Acetate Ophthalmic Suspension recall status
Official ID D-0655-2026 ·
Official record ↗
FDA Class III · Drug · July 8, 2026
Failed Impurities/Degradation Specifications
Company / brand: SUN PHARMACEUTICAL INDUSTRIES recalls
Affected product: Fexofenadine Hydrochloride Tablets recall status
Official ID D-0654-2026 ·
Official record ↗
FDA Class II · Drug · July 8, 2026
Lack of assurance of Sterility:
Company / brand: ACCORD BIOPHARMA recalls
Affected product: IMULDOSA recall status
Official ID D-0653-2026 ·
Official record ↗
FDA Class II · Drug · July 8, 2026
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of th…
Company / brand: CareFusion 213 recalls
Affected product: BD ChloraPrep CLear recall status
Official ID D-0652-2026 ·
Official record ↗
FDA Class II · Drug · July 8, 2026
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of th…
Company / brand: CareFusion 213 recalls
Affected product: BD ChloraPrep CLear recall status
Official ID D-0651-2026 ·
Official record ↗
FDA Class II · Drug · July 8, 2026
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of th…
Company / brand: CareFusion 213 recalls
Affected product: BD ChloraPrep Scrub Teal recall status
Official ID D-0650-2026 ·
Official record ↗
FDA Class II · Drug · July 8, 2026
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of th…
Company / brand: CareFusion 213 recalls
Affected product: BD ChloraPrep Scrub Teal recall status
Official ID D-0649-2026 ·
Official record ↗
FDA Class II · Drug · July 8, 2026
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of th…
Company / brand: CareFusion 213 recalls
Affected product: BD ChloraPrep Hi-Lite Orange recall status
Official ID D-0648-2026 ·
Official record ↗
FDA Class II · Drug · July 8, 2026
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of th…
Company / brand: CareFusion 213 recalls
Affected product: BD ChloraPrep Hi-Lite Orange recall status
Official ID D-0647-2026 ·
Official record ↗
FDA Class II · Drug · July 8, 2026
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of th…
Company / brand: CareFusion 213 recalls
Affected product: ChloraPrep FREPP recall status
Official ID D-0646-2026 ·
Official record ↗
FDA Class II · Drug · July 8, 2026
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of th…
Company / brand: CareFusion 213 recalls
Affected product: BD ChloraPrep Clear recall status
Official ID D-0645-2026 ·
Official record ↗
FDA Class II · Drug · July 8, 2026
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of th…
Company / brand: CareFusion 213 recalls
Affected product: BD PurPrep recall status
Official ID D-0644-2026 ·
Official record ↗
FDA Class II · Drug · July 8, 2026
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of th…
Company / brand: CareFusion 213 recalls
Affected product: BD ChloraPrep Hi-Lite Orange recall status
Official ID D-0643-2026 ·
Official record ↗
FDA Class II · Drug · July 1, 2026
Labeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled Perampanel 6 mg tablets.
Company / brand: SUN PHARMACEUTICAL INDUSTRIES recalls
Affected product: Perampanel CIII Tablets recall status
Official ID D-0628-2026 ·
Official record ↗
FDA Class II · Drug · July 1, 2026
sub potency
Company / brand: Elevate Oral Care recalls
Affected product: Povi-One recall status
Official ID D-0627-2026 ·
Official record ↗
FDA Class II · Drug · July 1, 2026
Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.
Company / brand: Annora Pharma Private recalls
Affected product: Lacosamide Tablets recall status
Official ID D-0626-2026 ·
Official record ↗
FDA Class I · Drug · July 1, 2026
Non-Sterility: Due to presence of Aspergillus penicillioides. And Lack of Assurance of Sterility: Due to wrinkles in the paper lidding which may breach the seal area.
Company / brand: CareFusion 213 recalls
Affected product: BD ChloraPrep FREPP Clear recall status
Official ID D-0625-2026 ·
Official record ↗
FDA Class I · Drug · July 1, 2026
Non-Sterility: Due to presence of Aspergillus penicillioides.
Company / brand: CareFusion 213 recalls
Affected product: BD ChloraPrep Clear (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (I recall status
Official ID D-0624-2026 ·
Official record ↗
FDA Class II · Drug · July 1, 2026
Lack of Assurance of Sterility: Due to wrinkles in the paper lidding which may breach the seal area.
Company / brand: CareFusion 213 recalls
Affected product: BD ChloraPrep FREPP Clear recall status
Official ID D-0623-2026 ·
Official record ↗
FDA Class II · Drug · July 1, 2026
Lack of Assurance of Sterility: Due to wrinkles in the paper lidding which may breach the seal area.
Company / brand: CareFusion 213 recalls
Affected product: BD ChloraPrep Clear recall status
Official ID D-0622-2026 ·
Official record ↗
FDA Class II · Drug · July 1, 2026
Lack of Assurance of Sterility
Company / brand: PReye recalls
Affected product: PReye Vitamin See Antioxidant Preservative Free Eye Drops recall status
Official ID D-0621-2026 ·
Official record ↗
FDA Class III · Drug · July 1, 2026
Presence of foreign substance
Company / brand: ANI Pharmaceuticals recalls
Affected product: hydrOXYzine Hydrochloride Oral Solution recall status
Official ID D-0619-2026 ·
Official record ↗
FDA Class II · Drug · July 1, 2026
Incorrect product formulation: bag did not contain copper and famotidine per label.
Company / brand: Central Admixture Pharmacy Services recalls
Affected product: Total Parental Nutrition - Pediatric PN Patient-Specific TPN Bag recall status
Official ID D-0618-2026 ·
Official record ↗
FDA Class II · Drug · July 1, 2026
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
Company / brand: Direct Rx recalls
Affected product: DULOXETINE D/R recall status
Official ID D-0617-2026 ·
Official record ↗
FDA Class II · Drug · July 1, 2026
CGMP Deviations
Company / brand: Amgen recalls
Affected product: Sensipar (cinacalcet) Tablets recall status
Official ID D-0616-2026 ·
Official record ↗
FDA Class II · Drug · July 1, 2026
Presence of Foreign Substance.
Company / brand: Amgen recalls
Affected product: Corlanor (ivabradine) tablets recall status
Official ID D-0615-2026 ·
Official record ↗
FDA Class II · Drug · July 1, 2026
CGMP Deviations
Company / brand: Amgen recalls
Affected product: Sensipar (cinacalcet) Tablets recall status
Official ID D-0614-2026 ·
Official record ↗
FDA Class II · Drug · July 1, 2026
CGMP Deviations
Company / brand: Amgen recalls
Affected product: Sensipar (cinacalcet) Tablets recall status
Official ID D-0613-2026 ·
Official record ↗
FDA Class II · Drug · July 1, 2026
Presence of Foreign Substance.
Company / brand: Amgen recalls
Affected product: Corlanor (ivabradine) tablets recall status
Official ID D-0612-2026 ·
Official record ↗
FDA Class II · Drug · July 1, 2026
CGMP Deviations
Company / brand: Ajanta Pharma USA recalls
Affected product: Fenofibrate Capsules recall status
Official ID D-0611-2026 ·
Official record ↗
FDA Class II · Drug · July 1, 2026
Subpotent Drug
Company / brand: The Harvard Drug Group recalls
Affected product: Carton Label recall status
Official ID D-0609-2026 ·
Official record ↗
FDA Class II · Drug · June 24, 2026
CGMP Deviations; deficiencies observed during FDA inspection
Company / brand: Dabur India recalls
Affected product: Med Pride recall status
Official ID D-0642-2026 ·
Official record ↗
FDA Class II · Drug · June 24, 2026
CGMP Deviations; deficiencies observed during FDA inspection
Company / brand: Dabur India recalls
Affected product: Med Pride recall status
Official ID D-0641-2026 ·
Official record ↗
FDA Class II · Drug · June 24, 2026
CGMP Deviations; deficiencies observed during FDA inspection
Company / brand: Dabur India recalls
Affected product: Med Pride recall status
Official ID D-0640-2026 ·
Official record ↗
FDA Class II · Drug · June 24, 2026
CGMP Deviations; deficiencies observed during FDA inspection
Company / brand: Dabur India recalls
Affected product: Med Pride recall status
Official ID D-0639-2026 ·
Official record ↗
FDA Class II · Drug · June 24, 2026
CGMP Deviations; deficiencies observed during FDA inspection
Company / brand: Dabur India recalls
Affected product: Med Pride recall status
Official ID D-0638-2026 ·
Official record ↗
FDA Class II · Drug · June 24, 2026
CGMP Deviations; deficiencies observed during FDA inspection
Company / brand: Dabur India recalls
Affected product: Med Pride recall status
Official ID D-0637-2026 ·
Official record ↗
FDA Class II · Drug · June 24, 2026
CGMP Deviations; deficiencies observed during FDA inspection
Company / brand: Dabur India recalls
Affected product: Med Pride recall status
Official ID D-0636-2026 ·
Official record ↗
FDA Class II · Drug · June 24, 2026
CGMP Deviations; deficiencies observed during FDA inspection
Company / brand: Dabur India recalls
Affected product: Med Pride recall status
Official ID D-0635-2026 ·
Official record ↗
FDA Class II · Drug · June 24, 2026
CGMP Deviations; deficiencies observed during FDA inspection
Company / brand: Dabur India recalls
Affected product: Cura Hongos recall status
Official ID D-0634-2026 ·
Official record ↗
FDA Class II · Drug · June 24, 2026
CGMP Deviations; deficiencies observed during FDA inspection
Company / brand: Dabur India recalls
Affected product: Rapidol recall status
Official ID D-0633-2026 ·
Official record ↗
FDA Class II · Drug · June 24, 2026
CGMP Deviations; deficiencies observed during FDA inspection
Company / brand: Dabur India recalls
Affected product: Lil Drug Store recall status
Official ID D-0632-2026 ·
Official record ↗
FDA Class II · Drug · June 24, 2026
CGMP Deviations; deficiencies observed during FDA inspection
Company / brand: Dabur India recalls
Affected product: Circle K recall status
Official ID D-0631-2026 ·
Official record ↗
FDA Class II · Drug · June 24, 2026
CGMP Deviations; deficiencies observed during FDA inspection
Company / brand: Dabur India recalls
Affected product: Lucky Super Soft recall status
Official ID D-0630-2026 ·
Official record ↗
FDA Class II · Drug · June 24, 2026
CGMP Deviations; deficiencies observed during FDA inspection
Company / brand: Dabur India recalls
Affected product: Lucky Super Soft recall status
Official ID D-0629-2026 ·
Official record ↗
FDA Class II · Drug · June 24, 2026
Failed Dissolution Specifications
Company / brand: Inventia Healthcare recalls
Affected product: Chlorthalidone Tablets recall status
Official ID D-0610-2026 ·
Official record ↗
FDA Class III · Drug · June 24, 2026
Labeling: Incorrect or Missing Lot and/or Exp Date
Company / brand: Sandoz recalls
Affected product: Focalin XR (dexmethylphenidate HCl) 5 mg recall status
Official ID D-0608-2026 ·
Official record ↗
FDA Class II · Drug · June 24, 2026
Defective container:may contain bottles with incomplete seals
Company / brand: Keystone Industries recalls
Affected product: safco SensiCaine-Ultra (20% Benzocaine) recall status
Official ID D-0606-2026 ·
Official record ↗
FDA Class II · Drug · June 24, 2026
Defective container:may contain bottles with incomplete seals
Company / brand: Keystone Industries recalls
Affected product: PureLife recall status
Official ID D-0605-2026 ·
Official record ↗
FDA Class II · Drug · June 24, 2026
Defective container:may contain bottles with incomplete seals
Company / brand: Keystone Industries recalls
Affected product: Dental City TOPICAL ANESTHETIC GEL recall status
Official ID D-0604-2026 ·
Official record ↗
FDA Class II · Drug · June 24, 2026
Defective container:may contain bottles with incomplete seals
Company / brand: Keystone Industries recalls
Affected product: Burkhart topical anesthetic gel recall status
Official ID D-0603-2026 ·
Official record ↗
FDA Class II · Drug · June 24, 2026
Defective container:may contain bottles with incomplete seals
Company / brand: Keystone Industries recalls
Affected product: DHP Topical Anesthetic Gel recall status
Official ID D-0602-2026 ·
Official record ↗
FDA Class II · Drug · June 24, 2026
Defective container:may contain bottles with incomplete seals
Company / brand: Keystone Industries recalls
Affected product: Quala Dental Products recall status
Official ID D-0601-2026 ·
Official record ↗
FDA Class II · Drug · June 24, 2026
Defective container:may contain bottles with incomplete seals
Company / brand: Keystone Industries recalls
Affected product: Pearson Quality Topical Anesthetic Gel (20% Benzocaine) recall status
Official ID D-0600-2026 ·
Official record ↗
FDA Class II · Drug · June 24, 2026
Crystallization; identified as Buprenorphine free base
Company / brand: Par Health USA recalls
Affected product: Buprenorphine HCl recall status
Official ID D-0596-2026 ·
Official record ↗
FDA Class II · Drug · June 24, 2026
Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.
Company / brand: Ajanta Pharma USA recalls
Affected product: Aripiprazole Tablets USP recall status
Official ID D-0594-2026 ·
Official record ↗
FDA Class II · Drug · June 24, 2026
Subpotent Drug
Company / brand: IntegraDose Compounding Services recalls
Affected product: Vasopressin 2 Units/2 mL in 0 recall status
Official ID D-0593-2026 ·
Official record ↗
FDA Class II · Drug · June 24, 2026
Does Not Meet USP or OTC Monograph: Product did not meet the Over-the-Counter (OTC) Monograph M023
Company / brand: PAI Holdings recalls
Affected product: VistaPharm recall status
Official ID D-0592-2026 ·
Official record ↗
FDA Class II · Drug · June 24, 2026
Does Not Meet USP or OTC Monograph: Product did not meet the Over-the-Counter (OTC) Monograph M023
Company / brand: PAI Holdings recalls
Affected product: VistaPharm recall status
Official ID D-0591-2026 ·
Official record ↗
FDA Class II · Drug · June 24, 2026
Does Not Meet USP or OTC Monograph: Product did not meet the Over-the-Counter (OTC) Monograph M023
Company / brand: PAI Holdings recalls
Affected product: VistaPharm recall status
Official ID D-0590-2026 ·
Official record ↗
FDA Class II · Drug · June 24, 2026
Does Not Meet USP or OTC Monograph: Product did not meet the Over-the-Counter (OTC) Monograph M023
Company / brand: PAI Holdings recalls
Affected product: VistaPharm recall status
Official ID D-0589-2026 ·
Official record ↗
FDA Class II · Drug · June 24, 2026
Failed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specification results total impurities.
Company / brand: Glenmark Pharmaceuticals recalls
Affected product: Alyacen 7/7/7 recall status
Official ID D-0588-2026 ·
Official record ↗
FDA Class I · Drug · June 17, 2026
Microbial Contamination of Non-Sterile Products
Company / brand: BEEKEEPER'S NATURALS USA recalls
Affected product: BEEKEEPER'S NATURALS Saline Nasal Spray recall status
Official ID D-0620-2026 ·
Official record ↗
FDA Class II · Drug · June 17, 2026
Presence of Foreign Substance:This recall has been initiated in response to a product quality complaint reported for black/brown specs and particles within the ampoule solution
Company / brand: SUN PHARMACEUTICAL INDUSTRIES recalls
Affected product: Budesonide Inhalation Suspension recall status
Official ID D-0607-2026 ·
Official record ↗
FDA Class II · Drug · June 17, 2026
Failed Dissolution Specifications: An out-of-specification (OOS) result was observed during the 9th month of dissolution test analysis
Company / brand: Ascend Laboratories recalls
Affected product: Minocycline Hydrochloride Extended-Release Tablets recall status
Official ID D-0597-2026 ·
Official record ↗
FDA Class I · Drug · June 17, 2026
Chemical Contamination: contamination with a diluted propylene glycol-based coolant from a machine leakage during the packaging process.
Company / brand: Haleon US Holdings recalls
Affected product: Gas-X Extra Strength recall status
Official ID D-0595-2026 ·
Official record ↗
FDA Class II · Drug · June 17, 2026
Failed Dissolution Specifications: During 12-month long-term stability testing, subject lot was out of specification (low) for stage 3 dissolution at the 24-hour timepoint.
Company / brand: Golden State Medical Supply recalls
Affected product: GSMS Incorporated recall status
Official ID D-0587-2026 ·
Official record ↗
FDA Class II · Drug · June 17, 2026
Microbial contamination of sterile products
Company / brand: Zep recalls
Affected product: Zep recall status
Official ID D-0586-2026 ·
Official record ↗
FDA Class III · Drug · June 17, 2026
Cross Contamination with Other Products: due to a potential for cross-contamination with Acemetacin API due to an issue at the API manufacturer.
Company / brand: Amneal Pharmaceuticals recalls
Affected product: Primidone Tablets recall status
Official ID D-0585-2026 ·
Official record ↗
FDA Class II · Drug · June 17, 2026
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
Company / brand: Breckenridge Pharmaceutical recalls
Affected product: Duloxetine Delayed-Release Capsules recall status
Official ID D-0583-2026 ·
Official record ↗
FDA Class II · Drug · June 17, 2026
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
Company / brand: Breckenridge Pharmaceutical recalls
Affected product: Duloxetine Delayed-Release Capsules recall status
Official ID D-0582-2026 ·
Official record ↗
FDA Class III · Drug · June 17, 2026
Failed Impurities/Degradations Specifications
Company / brand: Fresenius Kabi USA recalls
Affected product: Epinephrine Injection recall status
Official ID D-0581-2026 ·
Official record ↗
FDA Class I · Drug · June 17, 2026
Presence of Particulate matter: Particulate matter identified as glass.
Company / brand: SUN PHARMACEUTICAL INDUSTRIES recalls
Affected product: DOXOrubin Hydrochloride Liposome injection recall status
Official ID D-0580-2026 ·
Official record ↗
FDA Class II · Drug · June 10, 2026
Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product under the proprietary name Xyvona
Company / brand: SUN PHARMACEUTICAL INDUSTRIES recalls
Affected product: Xyvona (levorphanol tartrate tablets) recall status
Official ID D-0599-2026 ·
Official record ↗
FDA Class II · Drug · June 10, 2026
Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product under the proprietary name Xyvona
Company / brand: SUN PHARMACEUTICAL INDUSTRIES recalls
Affected product: Xyvona (levorphanol tartrate tablets) recall status
Official ID D-0598-2026 ·
Official record ↗
FDA Class II · Drug · June 10, 2026
Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.
Company / brand: Lannett Company recalls
Affected product: Niacin Extended-release Tablets recall status
Official ID D-0584-2026 ·
Official record ↗
FDA Class II · Drug · June 10, 2026
Presence of foreign substance: small metallic particles in chewable tablets.
Company / brand: Guardian Drug Co recalls
Affected product: TopCare health recall status
Official ID D-0579-2026 ·
Official record ↗
FDA Class II · Drug · June 10, 2026
Presence of foreign substance: small metallic particles in chewable tablets.
Company / brand: Guardian Drug Co recalls
Affected product: TopCare health recall status
Official ID D-0578-2026 ·
Official record ↗
FDA Class II · Drug · June 10, 2026
Presence of foreign substance: small metallic particles in chewable tablets.
Company / brand: Guardian Drug Co recalls
Affected product: EQUALINE ultra strength recall status
Official ID D-0577-2026 ·
Official record ↗
FDA Class II · Drug · June 10, 2026
Presence of foreign substance: small metallic particles in chewable tablets.
Company / brand: Guardian Drug Co recalls
Affected product: EQUALINE extra strength recall status
Official ID D-0576-2026 ·
Official record ↗
FDA Class II · Drug · June 10, 2026
Presence of foreign substance: small metallic particles in chewable tablets.
Company / brand: Guardian Drug Co recalls
Affected product: GOODSENSE Ultra Strength recall status
Official ID D-0575-2026 ·
Official record ↗
FDA Class II · Drug · June 10, 2026
Presence of foreign substance: small metallic particles in chewable tablets.
Company / brand: Guardian Drug Co recalls
Affected product: GOODSENSE Extra Strength recall status
Official ID D-0574-2026 ·
Official record ↗
FDA Class II · Drug · June 10, 2026
Presence of foreign substance: small metallic particles in chewable tablets.
Company / brand: Guardian Drug Co recalls
Affected product: H recall status
Official ID D-0573-2026 ·
Official record ↗
FDA Class II · Drug · June 10, 2026
Presence of foreign substance: small metallic particles in chewable tablets.
Company / brand: Guardian Drug Co recalls
Affected product: HyVee recall status
Official ID D-0572-2026 ·
Official record ↗
FDA Class II · Drug · June 10, 2026
Presence of foreign substance: small metallic particles in chewable tablets.
Company / brand: Guardian Drug Co recalls
Affected product: HyVee recall status
Official ID D-0571-2026 ·
Official record ↗
FDA Class II · Drug · June 10, 2026
Presence of foreign substance: small metallic particles in chewable tablets.
Company / brand: Guardian Drug Co recalls
Affected product: Harris Teeter recall status
Official ID D-0570-2026 ·
Official record ↗
FDA Class II · Drug · June 10, 2026
Presence of foreign substance: small metallic particles in chewable tablets.
Company / brand: Guardian Drug Co recalls
Affected product: FAMILY WELLNESS recall status
Official ID D-0569-2026 ·
Official record ↗
FDA Class II · Drug · June 10, 2026
Presence of foreign substance: small metallic particles in chewable tablets.
Company / brand: Guardian Drug Co recalls
Affected product: FAMILY WELLNESS recall status
Official ID D-0568-2026 ·
Official record ↗
FDA Class II · Drug · June 10, 2026
Presence of foreign substance: small metallic particles in chewable tablets.
Company / brand: Guardian Drug Co recalls
Affected product: DISCOUNT drug mart recall status
Official ID D-0567-2026 ·
Official record ↗
FDA Class II · Drug · June 10, 2026
Presence of foreign substance: small metallic particles in chewable tablets.
Company / brand: Guardian Drug Co recalls
Affected product: CAREone recall status
Official ID D-0566-2026 ·
Official record ↗
FDA Class II · Drug · June 10, 2026
Presence of foreign substance: small metallic particles in chewable tablets.
Company / brand: Guardian Drug Co recalls
Affected product: CAREone recall status
Official ID D-0565-2026 ·
Official record ↗
FDA Class II · Drug · June 10, 2026
Presence of foreign substance: small metallic particles in chewable tablets.
Company / brand: Guardian Drug Co recalls
Affected product: MARKET BASKET ANTACID Calcium Carbonate 1000 mg recall status
Official ID D-0564-2026 ·
Official record ↗
FDA Class II · Drug · June 10, 2026
Presence of foreign substance: small metallic particles in chewable tablets.
Company / brand: Guardian Drug Co recalls
Affected product: 24/7 life BY 7-ELEVEN recall status
Official ID D-0563-2026 ·
Official record ↗
FDA Class II · Drug · June 10, 2026
Presence of foreign substance: small metallic particles in chewable tablets.
Company / brand: Guardian Drug Co recalls
Affected product: Extra strength Antacid Calcium Carbonate 750 mg recall status
Official ID D-0562-2026 ·
Official record ↗
FDA Class II · Drug · June 10, 2026
Presence of foreign substance: small metallic particles in chewable tablets.
Company / brand: Guardian Drug Co recalls
Affected product: Good Neighbor Pharmacy recall status
Official ID D-0561-2026 ·
Official record ↗
FDA Class II · Drug · June 10, 2026
Presence of foreign substance: small metallic particles in chewable tablets.
Company / brand: Guardian Drug Co recalls
Affected product: Good Neighbor Pharmacy recall status
Official ID D-0560-2026 ·
Official record ↗
FDA Class II · Drug · June 10, 2026
Presence of foreign substance: small metallic particles in chewable tablets.
Company / brand: Guardian Drug Co recalls
Affected product: HALEON CALCIUM CARBONATE TUMS ANTACID recall status
Official ID D-0559-2026 ·
Official record ↗
FDA Class II · Drug · June 10, 2026
Presence of foreign substance: small metallic particles in chewable tablets.
Company / brand: Guardian Drug Co recalls
Affected product: HALEON CALCIUM CARBONATE TUMS ANTACID recall status
Official ID D-0558-2026 ·
Official record ↗
FDA Class II · Drug · June 10, 2026
Presence of foreign substance: small metallic particles in chewable tablets.
Company / brand: Guardian Drug Co recalls
Affected product: KIRKLAND Signature recall status
Official ID D-0557-2026 ·
Official record ↗
FDA Class II · Drug · June 10, 2026
Failed Dissolution Specifications: Olmesartan Medoxomil content below specifications
Company / brand: Ascend Laboratories recalls
Affected product: Amlodipine and Olmesartan Medoxomil Tablets recall status
Official ID D-0556-2026 ·
Official record ↗
FDA Class II · Drug · June 10, 2026
CGMP Deviations; presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the FDA acceptable intake limit.
Company / brand: Asclemed USA recalls
Affected product: Duloxetine DR Capsules recall status
Official ID D-0555-2026 ·
Official record ↗
FDA Class II · Drug · June 10, 2026
Lack of Assurance of Sterility
Company / brand: Spectra Medical Devices recalls
Affected product: Lidocaine HCl Injection USP recall status
Official ID D-0554-2026 ·
Official record ↗
FDA Class III · Drug · June 10, 2026
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
Company / brand: Eugia US recalls
Affected product: Lidocaine HCl Injection recall status
Official ID D-0552-2026 ·
Official record ↗
FDA Class III · Drug · June 3, 2026
Failed Stability Specifications
Company / brand: AbbVie recalls
Affected product: PRED MILD recall status
Official ID D-0551-2026 ·
Official record ↗
FDA Class III · Drug · June 3, 2026
Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of individual units.
Company / brand: AVEVA Drug Delivery Systems recalls
Affected product: Nicotine Transdermal System Patch recall status
Official ID D-0550-2026 ·
Official record ↗
FDA Class I · Drug · May 27, 2026
Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus.
Company / brand: Wisconsin Pharmacal Company recalls
Affected product: MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%) recall status
Official ID D-0553-2026 ·
Official record ↗
FDA Class II · Drug · May 27, 2026
Presence of a Foreign Substance; black particles observed in liquid
Company / brand: Safecor Health recalls
Affected product: Vitamin B-Complex recall status
Official ID D-0549-2026 ·
Official record ↗
FDA Class II · Drug · May 27, 2026
Subpotent Drug
Company / brand: IntegraDose Compounding Services recalls
Affected product: fentaNYL Citrate recall status
Official ID D-0548-2026 ·
Official record ↗
FDA Class II · Drug · May 27, 2026
Lack of Assurance of Sterility
Company / brand: UCB Biosciences recalls
Affected product: cimzia (certolizumab pegol) recall status
Official ID D-0546-2026 ·
Official record ↗
FDA Class II · Drug · May 27, 2026
CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit
Company / brand: Zydus Pharmaceuticals (USA) recalls
Affected product: Erythromycin Tablets recall status
Official ID D-0545-2026 ·
Official record ↗
FDA Class II · Drug · May 27, 2026
CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit
Company / brand: Zydus Pharmaceuticals (USA) recalls
Affected product: Erythromycin Tablets recall status
Official ID D-0544-2026 ·
Official record ↗
FDA Class II · Drug · May 27, 2026
Defective Container; packets were found to be either empty or partially full.
Company / brand: ANI Pharmaceuticals recalls
Affected product: Estradiol Gel recall status
Official ID D-0543-2026 ·
Official record ↗
FDA Class II · Drug · May 27, 2026
Labeling: Not Elsewhere Classified- Incomplete inactive ingredient information on the carton labeling.
Company / brand: Haleon US Holdings recalls
Affected product: Gas-X recall status
Official ID D-0542-2026 ·
Official record ↗
FDA Class II · Drug · May 27, 2026
Presence of particulate matter: a white thread-like structure in the cartridge
Company / brand: Lupin Pharmaceuticals recalls
Affected product: Liraglutide Injection recall status
Official ID D-0541-2026 ·
Official record ↗
FDA Class III · Drug · May 27, 2026
Failed Impurities/Degradation Specifications
Company / brand: Sagent Pharmaceuticals recalls
Affected product: Busulfan Injection recall status
Official ID D-0539-2026 ·
Official record ↗
FDA Class II · Drug · May 27, 2026
Labeling: Label Mix-Up: Atomoxetine HCl 25mg Capsule incorrectly labeled as Atomoxetine HCl 10mg Capsule.
Company / brand: Safecor Health recalls
Affected product: Atomoxetine Capsules HCL recall status
Official ID D-0538-2026 ·
Official record ↗
FDA Class III · Drug · May 27, 2026
Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.
Company / brand: Amerisource Health Services recalls
Affected product: Primidone Tablets recall status
Official ID D-0537-2026 ·
Official record ↗
FDA Class III · Drug · May 27, 2026
Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.
Company / brand: Amerisource Health Services recalls
Affected product: Primidone Tablets recall status
Official ID D-0536-2026 ·
Official record ↗
FDA Class III · Drug · May 27, 2026
Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.
Company / brand: Golden State Medical Supply recalls
Affected product: Primidone Tablets recall status
Official ID D-0535-2026 ·
Official record ↗
FDA Class III · Drug · May 27, 2026
Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.
Company / brand: Golden State Medical Supply recalls
Affected product: Primidone Tablets recall status
Official ID D-0534-2026 ·
Official record ↗
FDA Class III · Drug · May 27, 2026
Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.
Company / brand: Lannett Company recalls
Affected product: Primidone Tablets USP recall status
Official ID D-0533-2026 ·
Official record ↗
FDA Class II · Drug · May 20, 2026
Failed Dissolution Specifications
Company / brand: Ascend Laboratories recalls
Affected product: Ascend Laboratories recall status
Official ID D-0547-2026 ·
Official record ↗
FDA Class II · Drug · May 20, 2026
Crystallization; identified as Buprenorphine free base
Company / brand: ENDO USA recalls
Affected product: Buprenorphine Hydrochloride recall status
Official ID D-0527-2026 ·
Official record ↗
FDA Class II · Drug · May 20, 2026
Lack of Assurance of Sterility: The recall is being initiated out of an abundance of caution following FDA observations noted during a recent inspection of Excelvision.
Company / brand: Oasis Medical recalls
Affected product: Oasis Tears PF recall status
Official ID D-0525-2026 ·
Official record ↗
FDA Class I · Drug · May 13, 2026
Presence of Particulate Matter.
Company / brand: B BRAUN MEDICAL recalls
Affected product: Lactated Ringer's Injection USP recall status
Official ID D-0540-2026 ·
Official record ↗
FDA Class II · Drug · May 13, 2026
Incorrect Product Formulation: product did not contain insulin as listed in the label.
Company / brand: Central Admixture Pharmacy Services recalls
Affected product: TPN bag (patient specific) recall status
Official ID D-0524-2026 ·
Official record ↗
FDA Class II · Drug · May 13, 2026
Chemical contamination; presence of lead and lithium above specification
Company / brand: Acella Pharmaceuticals recalls
Affected product: NAPROXEN ORAL SUSPENSION recall status
Official ID D-0523-2026 ·
Official record ↗
FDA Class II · Drug · May 13, 2026
CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit
Company / brand: Breckenridge Pharmaceutical recalls
Affected product: Duloxetine Delayed-Release Capsules USP recall status
Official ID D-0522-2026 ·
Official record ↗
FDA Class II · Drug · May 13, 2026
Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test
Company / brand: JB Chemicals and Pharmaceuticals recalls
Affected product: Enalapril Maleate Tablets recall status
Official ID D-0520-2026 ·
Official record ↗
FDA Class II · Drug · May 13, 2026
Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.
Company / brand: Teva Pharmaceuticals USA recalls
Affected product: Octreotide Acetate for Injectable Suspension recall status
Official ID D-0519-2026 ·
Official record ↗
FDA Class II · Drug · May 13, 2026
Lack of assurance of Sterility: potential product contamination
Company / brand: CareFusion 213 recalls
Affected product: BD PurPrep recall status
Official ID D-0518-2026 ·
Official record ↗
Sources last checked October 22, 2026 at 12:00 PM UTC.